Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
INDIPENDENT PROGNOSTIC VALUE OF SOLUBLE-SUPRESSION OF TUMORIGENICITY (s-ST2) IN PATIENTS AFFECTED BY PULMONARY HYPERTENSION
Anno:
2024
Introduction: According to ESC 2022 guidelines, pulmonary hypertension (PH) is a hemodynamic condition characterized by mean pulmonary arterial pressure>20 mmHg. Pulmonary arterial hypertension (PAH) represents 5% of the PH, with an unfavorable prognosis primarily because of late diagnosis and treatment. In PAH, it is important to evaluate the individual…
Leggi di più
HIGH LEVELS OF SOLUBLE-SUPRESSION OF TUMORIGENICITY(s-ST2) PREDICT RIGHT VENTRICULAR/PULMONARY ARTERY UNCOUPLING WITH TAPSE/PAPs IN PATIENTS AFFECTED BY PULMONARY HYPERTENSION
Anno:
2024
Introduction: Pulmonary hypertension (PH) is a disease with an unfavorable prognosis, characterized by increasing in pulmonary resistence and right heart failure. One of the most important prognostic factors is the adaptation of the right ventricle to increased pressure overload, witch can be evaluated through tricuspid annular plane systolic excursion/systolic…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram